Is Ekso Bionics Holdings, Inc. Common Stock a good investment? Ekso Bionics Holdings, Inc. Common Stock (CHRN) is currently trading at 22.86 USD.
Earnings Schedule: Ekso Bionics Holdings, Inc. Common Stock is expected to release its next earnings report on Sept. 21, 2026.
No, it does not currently pay a dividend.
Ekso Bionics Holdings, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Sept. 21, 2026. The company currently has a trailing EPS of -0.51.
ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
Community Discussion